A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli

AbstractThe use of daptomycin (DAP) in septic pulmonary emboli (SPE) remains controversial. We analyzed 29 cases of MRSA bacteremia complicated by SPE treated with DAP (n = 14) or DAP-ceftaroline fosamil (CPT;n = 15). Initial treatment with DAP monotherapy was found to have a success rate comparable with DAP-CPT (71% vs. 80%;p = 0.68).

http://link.springer.com/10.1007/s10096-020-03941-5

Source: European Journal of Clinical Microbiology and Infectious Diseases - June 12, 2020 Category: Microbiology Source Type: research